Exploring gene regulatory interaction networks and predicting therapeutic molecules for hypopharyngeal cancer and EGFR-mutated lung adenocarcinoma

dc.contributor.authorBhattacharjya, Abanti
dc.contributor.authorManowarul Islam, Md
dc.contributor.authorUddin, Md Ashraf
dc.contributor.authorTalukder, Md Alamin
dc.contributor.authorAzad, AkM
dc.contributor.authorAryal, Sunil
dc.contributor.authorPaul, Bikash Kumar
dc.contributor.authorTasnim, Wahia
dc.date.accessioned2025-11-05T06:24:54Z
dc.date.available2025-11-05T06:24:54Z
dc.date.issued2024-03-23
dc.descriptionArticle
dc.description.abstractHypopharyngeal cancer is a disease that is associated with EGFR-mutated lung adenocarcinoma. Here we utilized a bioinformatics approach to identify genetic commonalities between these two diseases. To this end, we examined microarray datasets from GEO (Gene Expression Omnibus) to identify differentially expressed genes, common genes, and hub genes between the selected two diseases. Our analyses identified potential therapeutic molecules for the selected diseases based on 10 hub genes with the highest interactions according to the degree topology method and the maximum clique centrality (MCC). These therapeutic molecules may have the potential for simultaneous treatment of these diseases.
dc.identifier.otherhttp://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/15459
dc.identifier.urihttp://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/15459
dc.language.isoen_US
dc.sourceDIU Institutional Repository
dc.subjectEGFR‐mutated lung adenocarcinoma
dc.subjectGene Expression Omnibus
dc.subjectDegree topology
dc.subjectTherapeutic molecule
dc.subjectHub gene
dc.subjectHypopharyngeal cancer
dc.titleExploring gene regulatory interaction networks and predicting therapeutic molecules for hypopharyngeal cancer and EGFR-mutated lung adenocarcinoma
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
947.pdf
Size:
116.57 KB
Format:
Adobe Portable Document Format

Collections